[Phase 1 clinical study of 123I-iomazenil: a new probe to evaluate central-type benzodiazepine receptor with SPECT].

Source:http://linkedlifedata.com/resource/pubmed/id/7897872

Download in:

View as

General Info

PMID
7897872